• editor@pphm.life
  • Evidence. Experts. Context.
Health news, backed by evidence.
PP Health Malaysia Banner (PPHM)

Huge Blood Analysis Predicts Likelihood of Developing Long COVID

A new study published in Science has revealed the development of a groundbreaking computational model that can predict the likelihood of an individual developing long COVID. Long COVID refers to the persistence of symptoms such as fatigue and brain fog for months or even years after an individual has been infected with the SARS-CoV-2 virus.

In this study, researchers analysed more than 6,500 proteins found in blood samples from individuals who had tested positive for COVID-19. By comparing these samples with those from healthy adults, the team identified significant differences in protein composition between individuals with long COVID, those who had recovered, and those who had never been infected.

The study indicates that proteins associated with immune responses, blood clotting, and inflammation could serve as key biomarkers for diagnosing and monitoring long COVID. This condition affects an estimated 65 million people worldwide and has been linked to over 200 symptoms, including brain fog, fatigue, chest pain, and breathlessness.

Experts expressed hope that this research will pave the way for further studies and the development of effective therapies for long COVID, which is currently challenging to treat.

The study involved 39 healthy adults who had never tested positive for COVID-19, as well as 113 individuals who had contracted the virus. Among the latter group, 40 individuals experienced long COVID, defined as the persistence of symptoms for at least six months after the initial infection. Remarkably, 22 individuals still exhibited symptoms even after 12 months.

The researchers analysed a total of 6,596 proteins across 268 blood samples collected from the participants during the acute phase of infection and again six months later. They discovered several notable differences in the blood of individuals with long COVID compared to those without the condition. Specifically, they observed an imbalance in proteins involved in blood clotting and inflammation.

Furthermore, when examining blood cells from a subset of participants, the researchers found that a protein called CD41, typically found on platelets involved in clotting, was present at its lowest levels in healthy individuals and highest in those with 12-month long COVID. This abnormal clumping of white blood cells may contribute to the formation of microclots, potentially blocking oxygen flow to tissues and causing some long COVID symptoms.

The researchers also noted increased activation of the complement system, a vital part of the body’s immune response, in individuals with long COVID. This activation was observed both during the initial infection and six months later. Additionally, those with long COVID exhibited imbalances in certain proteins involved in the complement system, potentially leading to tissue damage.

Using machine learning, the researchers developed a model to predict the likelihood of an individual developing long COVID based on their blood protein levels, age, and body mass index. When applied to a separate dataset, the model demonstrated excellent performance in predicting individuals who would experience long COVID for at least 12 months.

While these findings align with existing theories regarding the causes of long COVID, they do not pinpoint the root cause of the condition, which remains a significant obstacle in developing effective treatments. Researchers emphasise that this study represents just the beginning of exploring this emerging field, and further investigations with larger sample sizes are necessary to fully comprehend the heterogeneity of long COVID and its underlying mechanisms.

This groundbreaking research offers new hope for understanding and managing long COVID. By identifying key protein biomarkers and developing a predictive model, scientists are taking significant strides towards improving diagnosis, monitoring, and ultimately finding effective therapies for this debilitating condition.

Disclaimer: Editorial content on this site is for general information only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider with any questions about your health. While we take care to ensure accuracy, we make no guarantees and accept no responsibility for any errors, omissions, outdated information or any consequences arising from use of this site. Views expressed in articles, interviews and features are those of the authors or contributors and do not  necessarily reflect the views of the publisher. References to, or advertisements for, products or services do not constitute endorsements, and we do not guarantee their quality, safety or effectiveness. You can read our editorial policy.